Ambit Biosciences
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4215 Sorrento Valley Blvd, San Diego, Ca...Phone Number
(858) 334-2100Website
www.ambitbio.comRevenue
$25.7 MillionIndustry
About Ambit Biosciences
Ambit Biosciences Corporation is a biopharmaceutical company dedicated to the discovery, development, and commercialization of drugs targeting unmet medical needs in oncology, autoimmune, and inflammatory diseases through kinase inhibition. Their product pipeline includes several programs, with quizartinib being the lead candidate, a once-daily oral FLT3 kinase inhibitor for acute myeloid leukemia. The company leverages its expertise in kinase research to develop a sustainable pipeline of small molecule inhibitors. Ambit also offers profiling services and clinical development expertise, positioning itself as a partner of choice in the kinase domain.Explore more
Ambit Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Ambit Biosciences
Compare insights from companies similar to Ambit Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ambit Biosciences
$25.7M
51-200
Private
-
2000
DM
Donald MyllChief Financial Officer & Senior VP, Commercial Operations
Ambit Biosciences Tech Stack
A closer look at the technologies used by Ambit Biosciences
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ambit Biosciences
Sign Up For FreeTo access detailed company insights
Ambit Biosciences Corporation is a biopharmaceutical company dedicated to the discovery, development, and commercialization of drugs targeting unmet medical needs in oncology, autoimmune, and inflammatory diseases through kinase inhibition. Their product pipeline includes several programs, with quizartinib being the lead candidate, a once-daily ora... Read More
